Barriers to treatment of chronic hepatitis C with direct acting antivirals in an urban clinic

Barriers to treatment of chronic hepatitis C with direct acting antivirals in an urban clinic

Introduction and aim: Direct-acting antiviral (DAA) agents are highly effective for treatment of chronic hepatitis C virus (HCV) yet access to treatment remains a serious challenge. The aim of this study was to identify barriers to treatment initiation with DAA-containing regimens in an urban clinic...

Full description

Bibliographic Details
Main Authors: Miguel Malespin, Ciel Harris, Ozdemir Kanar, Kelly Jackman, Carmen Smotherman, Abbey Johnston, Julie Ferm, Silvio W. de Melo, Jr, James S. Scolapio, David R. Nelson, Scott J. Cotler
Format: Article
Language:English
Published: Elsevier 2019-03-01
Series:Annals of Hepatology
Subjects:
Chronic hepatitis C
Direct acting antivirals
Barriers to treatment
Psychosocial factors
Online Access:http://www.sciencedirect.com/science/article/pii/S1665268119300067

Internet

http://www.sciencedirect.com/science/article/pii/S1665268119300067

Similar Items